Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: Stability and immunoefficiency studies
Authors:
- Manish GautamMGManish Gautam
- Sunil GairolaSGSunil Gairola
- Suresh JadhavSJSuresh Jadhav
- Varsha PokharkarVPVarsha Pokharkar
- 1 January 2013
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 441 (1-2) , 636-642
Abstract
No abstract availableKeywords
Funding Information
- AICTE, New Delhi
This publication has 34 references indexed in Scilit:
- Cellular transport pathways of polymer coated gold nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Natural and synthetic saponin adjuvant QS-21 for vaccines against cancerExpert Review of Vaccines, 2011
- Induction of humoral immune response against PfMSP-119 and PvMSP-119 using gold nanoparticles along with alumVaccine, 2011
- Prevention of Rotavirus Infections In Vitro with Aqueous Extracts of Quillaja Saponaria MolinaFuture Medicinal Chemistry, 2010
- Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis BJournal of Drug Targeting, 2010
- Mucosal Vaccines: Recent Progress in Understanding the Natural BarriersPharmaceutical Research, 2009
- Secondary structure of food proteins by Fourier transform spectroscopy in the mid-infrared regionAmino Acids, 2009
- In vitro and in vivo evaluation of mucoadhensiveness of chitosan/cellulose acetate multimicrospheresJournal of Biomedical Materials Research Part A, 2007
- Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticlesVaccine, 2004
- Adjuvants of ImmunityJournal of Experimental Medicine, 2002